Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AI-Enhanced Risk Stratification for Targeted Chalazion Management: A Prospective Study on the Efficacy of Triamcinolone Acetonide and Intense Pulsed Light Therapy

  • By

  • Yanlin Zhong

  • Yiming Hu

  • Yuan Lin

  • Huping Wu

  • June 15, 2026

Share

Original Source(s)

Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy

  • by Yanlin Zhong, Yiming Hu, Yuan Lin, Huping Wu

  • June 15, 2026

Related Content

Managing Ocular Surface Disease

Early recognition of ocular surface disease may enable timely intervention with medications, procedures, and homecare practices, which may limit ocular surface damage and reduce patient symptom severity.

Research Review:<br> TFOS DEWS III Summary Pertaining to Contact Lenses</br>

Prevalence of Meibomian Gland Dysfunction in the Upper Eyelid Among Postmenopausal Women with Primary Acquired Nasolacrimal Duct Obstruction